Chelo Rayón

2.2k total citations
15 papers, 871 citations indexed

About

Chelo Rayón is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Chelo Rayón has authored 15 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 12 papers in Molecular Biology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Chelo Rayón's work include Acute Myeloid Leukemia Research (13 papers), Retinoids in leukemia and cellular processes (12 papers) and Acute Lymphoblastic Leukemia research (5 papers). Chelo Rayón is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Retinoids in leukemia and cellular processes (12 papers) and Acute Lymphoblastic Leukemia research (5 papers). Chelo Rayón collaborates with scholars based in Spain, Argentina and Netherlands. Chelo Rayón's co-authors include Miguel Á. Sanz, Giuseppe Milone, Pau Montesinos, Javier de la Serna, Bob Löwenberg, Salut Brunet, Concha Rivas, José D. González, Juan Bergua and Joaquı́n Dı́az-Mediavilla and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Chelo Rayón

14 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chelo Rayón Spain 7 758 748 222 163 101 15 871
Concha Rivas Spain 6 643 0.8× 649 0.9× 209 0.9× 127 0.8× 90 0.9× 9 746
A. Stamatoulas France 5 338 0.4× 286 0.4× 28 0.1× 76 0.5× 15 0.1× 9 449
Laurence Detourmignies France 9 237 0.3× 195 0.3× 22 0.1× 86 0.5× 9 0.1× 16 402
A. Cantù Rajnoldi Italy 8 379 0.5× 195 0.3× 19 0.1× 115 0.7× 12 0.1× 12 465
F Teillet France 8 140 0.2× 161 0.2× 60 0.3× 27 0.2× 2 0.0× 30 367
Rocco Pastano Italy 10 177 0.2× 80 0.1× 10 0.0× 54 0.3× 8 0.1× 19 285
Giacomo Gianfaldoni Italy 14 324 0.4× 114 0.2× 6 0.0× 121 0.7× 5 0.0× 34 468
A Miliani Italy 6 195 0.3× 122 0.2× 10 0.0× 14 0.1× 16 0.2× 24 320
Ilaria Ambaglio Italy 8 750 1.0× 164 0.2× 3 0.0× 90 0.6× 44 0.4× 15 798
Daigo Akahane Japan 10 139 0.2× 85 0.1× 6 0.0× 18 0.1× 6 0.1× 46 277

Countries citing papers authored by Chelo Rayón

Since Specialization
Citations

This map shows the geographic impact of Chelo Rayón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chelo Rayón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chelo Rayón more than expected).

Fields of papers citing papers by Chelo Rayón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chelo Rayón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chelo Rayón. The network helps show where Chelo Rayón may publish in the future.

Co-authorship network of co-authors of Chelo Rayón

This figure shows the co-authorship network connecting the top 25 collaborators of Chelo Rayón. A scholar is included among the top collaborators of Chelo Rayón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chelo Rayón. Chelo Rayón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Montesinos, Pau, José D. González, José González, et al.. (2010). Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based Chemotherapy. Journal of Clinical Oncology. 28(24). 3872–3879. 49 indexed citations
2.
3.
Cervera, José, Pau Montesinos, José‐Ángel Hernández‐Rivas, et al.. (2009). Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Haematologica. 95(3). 424–431. 50 indexed citations
4.
5.
6.
Serna, Javier de la, Pau Montesinos, Edo Vellenga, et al.. (2008). Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood. 111(7). 3395–3402. 246 indexed citations
7.
8.
9.
Montesinos, Pau, José D. González, Chelo Rayón, et al.. (2007). Secondary Acute Myeloid Leukemia and Myelodysplastic Syndromes Following ATRA and Anthracycline Monochemotherapy Treatment for Acute Promyelocytic Leukemia.. Blood. 110(11). 1838–1838. 1 indexed citations
10.
Montesinos, Pau, José D. González, Edo Vellenga, et al.. (2007). Central Nervous System Relapse in Patients with Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid and Reinforced Anthracycline Monochemotherapy.. Blood. 110(11). 592–592. 1 indexed citations
11.
Sanz, Miguel Á., Pau Montesinos, Edo Vellenga, et al.. (2007). Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Updated Results of the Spanish PETHEMA LPA99 Trial Using ATRA and Anthracycline Monochemotherapy.. Blood. 110(11). 590–590. 1 indexed citations
12.
13.
Cervera, José, Marı́a José Calasanz, José A. Martínez-Climent, et al.. (2001). Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA.. PubMed. 86(8). 807–13. 49 indexed citations
14.
Bárez, Abelardo, et al.. (1992). [Features of chronic myeloid leukemia at diagnosis. Study of a series of 134 cases].. PubMed. 37(5). 345–50. 2 indexed citations
15.
Condé, E., A Iriondo, Chelo Rayón, et al.. (1988). Allogeneic bone marrow transplantation versus intensification chemotherapy for acute myelogenous leukaemia in first remission: a prospective controlled trial. British Journal of Haematology. 68(2). 219–226. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Concha Rivas Breakdown of academic impact, for papers by A. Stamatoulas Breakdown of academic impact, for papers by Laurence Detourmignies Breakdown of academic impact, for papers by A. Cantù Rajnoldi Breakdown of academic impact, for papers by F Teillet Breakdown of academic impact, for papers by Rocco Pastano Breakdown of academic impact, for papers by Giacomo Gianfaldoni Breakdown of academic impact, for papers by A Miliani Breakdown of academic impact, for papers by Ilaria Ambaglio Breakdown of academic impact, for papers by Daigo Akahane
Rankless by CCL
2026